Skip to main content
CV
NASDAQ Life Sciences

CapsoVision Misses Q3 Estimates With 15-Cent Loss, Revenue Flat at $3.57M

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.27
Mkt Cap
$333.629M
52W Low
$4.5
52W High
$15.37
52W Position info
39% above low
Off High info
59% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CV sits 39% above its 52-week low of $4.5.

Summary

CapsoVision posted a Q3 adjusted loss of 15 cents a share, a penny worse than the 14-cent consensus and wider than the 17-cent loss a year ago on a reported basis. Revenue came in at $3.57 million, up 0.8% but below the $3.76 million analysts expected, and the company swung to a $7.34 million quarterly loss. The results land alongside the 10-Q filed tonight, which formally states substantial doubt about the company's ability to continue as a going concern — a red flag for a micro-cap that has been leaning on its $100 million ATM and a September $18 million direct offering at $5.69. Analysts have already cut their mean earnings estimate by about 20.8% over the past three months, and the stock is down 41.3% year to date. The lone bright spot remains the September FDA clearance of the AI Highlights tool for CapsoCam Plus, but it has not yet shown up in revenue.

At the time of this announcement, CV was trading at $6.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $333.6M. The 52-week trading range was $4.50 to $15.37. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CV - Latest Insights

CV
Nov 12, 2026, 4:39 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.27
Real-time Price: $6.27 info
Change: $0 (0%) info
Market Cap: $333.629M info
CV
Sep 28, 2026, 9:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $6.78
Real-time Price: $6.27 info
Change: -$0.5077 (-7%) info
Market Cap: $333.629M info
CV
Sep 23, 2026, 9:01 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $6.27 info
Change: +$0.170 (+3%) info
Market Cap: $333.629M info
CV
Sep 18, 2026, 6:14 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $6.70
Real-time Price: $6.27 info
Change: -$0.430 (-6%) info
Market Cap: $333.629M info
CV
Sep 18, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $6.27 info
Change: -$0.430 (-6%) info
Market Cap: $333.629M info